NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 23 04:00PM ET
120.22
Dollar change
+1.04
Percentage change
0.87
%
Index- P/E24.82 EPS (ttm)4.84 Insider Own1.61% Shs Outstand100.90M Perf Week-0.58%
Market Cap12.12B Forward P/E21.52 EPS next Y5.59 Insider Trans-10.05% Shs Float99.18M Perf Month0.31%
Enterprise Value15.43B PEG2.19 EPS next Q1.21 Inst Own96.57% Short Float0.89% Perf Quarter23.81%
Income492.00M P/S2.20 EPS this Y13.18% Inst Trans0.56% Short Ratio1.05 Perf Half Y24.01%
Sales5.51B P/B5.62 EPS next Y11.41% ROA7.68% Short Interest0.88M Perf YTD30.18%
Book/sh21.40 P/C72.39 EPS next 5Y11.33% ROE25.33% 52W High123.13 -2.36% Perf Year40.84%
Cash/sh1.66 P/FCF31.36 EPS past 3/5Y2.72% 4.32% ROIC10.48% 52W Low82.74 45.30% Perf 3Y169.52%
Dividend Est.0.69 (0.57%) EV/EBITDA12.52 Sales past 3/5Y10.20% 3.13% Gross Margin20.59% Volatility0.89% 0.76% Perf 5Y124.94%
Dividend TTM0.66 (0.55%) EV/Sales2.80 EPS Y/Y TTM30.38% Oper. Margin16.76% ATR (14)2.18 Perf 10Y223.84%
Dividend Ex-DateJul 01, 2025 Quick Ratio1.06 Sales Y/Y TTM11.21% Profit Margin8.93% RSI (14)56.25 Recom1.21
Dividend Gr. 3/5Y-17.02% -10.27% Current Ratio1.06 EPS Q/Q34.79% SMA20-0.05% Beta0.91 Target Price131.58
Payout14.35% Debt/Eq1.25 Sales Q/Q10.59% SMA504.14% Rel Volume0.62 Prev Close119.18
Employees40000 LT Debt/Eq1.18 EarningsApr 24 AMC SMA20017.91% Avg Volume840.32K Price120.22
IPOSep 24, 1986 Option/ShortYes / Yes EPS/Sales Surpr.15.36% 1.80% Trades Volume525,853 Change0.87%
Date Action Analyst Rating Change Price Target Change
Oct-11-24Initiated KeyBanc Capital Markets Overweight $115
Jul-10-24Initiated Leerink Partners Outperform $100
Mar-06-24Initiated Barclays Overweight $95
Mar-14-23Initiated Barclays Equal Weight $57
Sep-24-21Initiated UBS Buy $98
Aug-02-21Upgrade Raymond James Outperform → Strong Buy $95 → $107
Nov-23-20Upgrade Barclays Equal Weight → Overweight $96
Aug-20-20Resumed Barclays Equal Weight $71
Dec-11-19Downgrade Wells Fargo Market Perform → Underperform
Oct-22-19Resumed Stephens Overweight
Jun-22-25 11:28PM
Jun-20-25 11:53AM
09:40AM
Jun-19-25 01:03PM
05:49AM
04:30PM Loading…
Jun-18-25 04:30PM
Jun-16-25 09:35AM
Jun-12-25 09:50AM
Jun-10-25 09:40AM
Jun-09-25 09:45AM
Jun-06-25 08:42AM
Jun-04-25 09:40AM
08:36AM
Jun-02-25 09:30AM
09:15AM
09:41AM Loading…
May-29-25 09:41AM
May-27-25 11:17AM
08:39AM
May-26-25 12:01AM
May-23-25 03:11PM
07:28AM
May-21-25 01:22PM
06:09AM
05:43AM
May-20-25 01:26PM
01:05PM
07:45AM
May-19-25 09:40AM
06:56AM
May-15-25 09:15AM
08:54AM Loading…
08:54AM
May-14-25 10:51AM
May-13-25 11:06AM
08:28AM
May-12-25 04:30PM
May-11-25 07:00AM
May-08-25 11:33AM
May-07-25 12:00PM
09:45AM
May-05-25 12:00PM
12:36AM
May-02-25 06:12PM
10:09AM
09:40AM
12:41AM
May-01-25 12:46PM
12:43PM
11:39AM
09:08AM
Apr-30-25 01:41PM
09:50AM
Apr-28-25 04:30PM
10:59AM
09:15AM
03:04AM
Apr-26-25 03:04AM
12:35AM
Apr-25-25 11:29PM
04:26PM
12:00PM
Apr-24-25 07:00PM
05:50PM
05:22PM
04:48PM
04:24PM
04:20PM
Apr-23-25 05:55PM
08:05AM
Apr-22-25 09:40AM
Apr-21-25 09:45AM
09:15AM
05:25AM
Apr-18-25 04:30PM
05:07AM
Apr-16-25 04:30PM
09:40AM
Apr-14-25 09:50AM
Apr-11-25 06:21AM
Apr-10-25 01:27PM
Apr-09-25 04:30PM
12:31PM
Apr-07-25 04:30PM
Apr-04-25 09:45AM
Mar-31-25 09:40AM
Mar-28-25 05:10AM
Mar-27-25 11:59AM
Mar-25-25 09:50AM
Mar-19-25 12:53PM
09:45AM
06:41AM
Mar-18-25 02:28PM
Mar-17-25 09:01AM
Mar-14-25 09:40AM
Mar-10-25 11:09AM
Feb-28-25 09:50AM
Feb-26-25 04:15PM
Feb-20-25 08:58AM
Feb-19-25 08:10AM
Feb-12-25 08:06AM
Feb-08-25 02:07AM
Encompass Health Corp. engages in the provision of post-acute healthcare services. It provides specialized rehabilitative treatment on an inpatient basis. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tarr Mark JPresident & CEOMay 20 '25Option Exercise40.10118,3844,747,113645,454May 20 05:08 PM
Tarr Mark JPresident & CEOMay 20 '25Sale121.53118,38414,387,152527,070May 20 05:08 PM
Mark TarrOfficerMay 20 '25Proposed Sale121.50118,38414,383,656May 20 05:00 PM
Charbonneau Elissa JoyChief Medical OfficerMay 06 '25Sale116.614,279498,97411,958May 07 01:07 PM
Darby John PatrickEVP, Gen Counsel & SecretaryApr 29 '25Option Exercise35.0610,000350,60089,710Apr 30 01:26 PM
Darby John PatrickEVP, Gen Counsel & SecretaryApr 29 '25Sale114.7910,0001,147,90079,710Apr 30 01:26 PM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerApr 29 '25Option Exercise31.5143,5751,372,990103,910Apr 30 01:24 PM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerApr 29 '25Sale115.1543,5755,017,53860,335Apr 30 01:24 PM
John Patrick DarbyOfficerApr 29 '25Proposed Sale114.7914,8581,705,539Apr 29 03:51 PM
Douglas Edward ColtharpOfficerApr 29 '25Proposed Sale115.1543,5755,017,565Apr 29 03:45 PM
Price Andrew LChief Accounting OfficerFeb 13 '25Sale98.295,042495,57869,164Feb 13 05:02 PM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerAug 13 '24Option Exercise35.8312,260439,276148,487Aug 14 03:03 PM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerAug 13 '24Sale86.3412,2601,058,474136,227Aug 14 03:03 PM
Douglas ColtharpOfficerAug 13 '24Proposed Sale86.3412,2601,058,520Aug 13 04:48 PM